• 1. Exchanged ligands on the surface of a giant cluster: [(MoO3)176(H2O)63(CH3OH)17Hn](32 – n)–
  Chem. Commun., 1998, 1501-1502
• 2. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
• 3. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 4. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 5. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Amphetamines and derivatives
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Phenethylamines Amphetamines and derivatives

Comprehensive Overview of (2R)-1-3-(trifluoromethyl)phenylpropan-2-amine (CAS No. 37577-22-3)

(2R)-1-3-(trifluoromethyl)phenylpropan-2-amine, with the CAS number 37577-22-3, is a chiral compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, also known as R-fluoxetine, is a key intermediate in the synthesis of various pharmaceuticals and is notable for its unique chemical structure and biological activity.

The chemical structure of (2R)-1-3-(trifluoromethyl)phenylpropan-2-amine features a chiral center at the second carbon of the propyl chain, which is crucial for its enantiomeric specificity. The presence of a trifluoromethyl group on the phenyl ring imparts unique electronic and steric properties to the molecule, making it an important building block in the design and synthesis of novel drugs.

Recent studies have highlighted the potential applications of (2R)-1-3-(trifluoromethyl)phenylpropan-2-amine in various therapeutic areas. One notable application is in the development of antidepressants. Fluoxetine, a well-known selective serotonin reuptake inhibitor (SSRI), is derived from this compound. The enantiomeric purity of (2R)-1-3-(trifluoromethyl)phenylpropan-2-amine is critical for ensuring the efficacy and safety of fluoxetine, as the R-enantiomer is responsible for its therapeutic effects.

In addition to its role in antidepressant therapy, (2R)-1-3-(trifluoromethyl)phenylpropan-2-amine has shown promise in other areas of medicinal chemistry. For instance, it has been investigated as a potential lead compound for the development of new antiviral agents. The trifluoromethyl group can enhance the lipophilicity and metabolic stability of drug candidates, which are essential properties for effective antiviral drugs.

The synthesis of (2R)-1-3-(trifluoromethyl)phenylpropan-2-amine typically involves several steps, including asymmetric synthesis to ensure enantiomeric purity. Recent advancements in catalytic asymmetric synthesis have made it possible to produce this compound with high yield and enantioselectivity. These developments have significantly reduced the cost and complexity of large-scale production, making it more accessible for pharmaceutical research and development.

In terms of biological activity, (2R)-1-3-(trifluoromethyl)phenylpropan-2-amine has been shown to interact with various neurotransmitter receptors, particularly serotonin receptors. This interaction is crucial for its therapeutic effects in treating depression and other mood disorders. Preclinical studies have demonstrated that this compound can modulate serotonin levels in the brain, leading to improved mood and reduced anxiety.

Clinical trials involving compounds derived from (2R)-1-3-(trifluoromethyl)phenylpropan-2-amine have also yielded promising results. For example, a phase II clinical trial evaluating a new SSRI based on this compound showed significant improvements in symptoms of major depressive disorder compared to placebo. These findings underscore the potential of (2R)-1-3-(trifluoromethyl)phenylpropan-2-amine as a valuable starting material for developing effective antidepressants.

Beyond its pharmaceutical applications, (2R)-1-3-(trifluoromethyl)phenylpropan-2-amine has also found use in academic research. Its unique chemical properties make it an excellent model compound for studying chiral recognition and enantioselective catalysis. Researchers have used this compound to develop new methods for asymmetric synthesis and to gain insights into the mechanisms underlying enantioselective reactions.

In conclusion, (2R)-1-3-(trifluoromethyl)phenylpropan-2-amine (CAS No. 37577-22-3) is a versatile and important compound with significant implications in medicinal chemistry and pharmaceutical research. Its unique chemical structure and biological activity make it an invaluable tool for developing new drugs and advancing our understanding of chiral chemistry. As research continues to uncover new applications and improve synthetic methods, the importance of this compound is likely to grow even further.

• 83616-19-7(Benzeneethanamine, alpha-propyl-3-(trifluoromethyl)-, (+-)-)
• 1886-26-6(Desethyl Fenfluramine)
• 37936-89-3((+)-Norfenfluramine hydrochloride)
• 1626-74-0(2-Amino-1-4-(trifluoromethyl)phenylpropane)
• 19036-73-8((2S)-1-3-(trifluoromethyl)phenylpropan-2-amine)
• 1645-09-6(2-methyl-1-3-(trifluoromethyl)phenylpropan-2-amine)
• 673-18-7(Norfenfluramine)
• 74051-20-0(Benzeneethanamine, a-ethyl-3-(trifluoromethyl)-)
• 89763-80-4(Benzeneethanamine, a-ethyl-4-(trifluoromethyl)-)
• 89763-79-1(Benzeneethanamine, α-ethyl-4-(trifluoromethyl)-, hydrochloride (1:1))